While opioid use disorders among teens and young adults are increasing, the number of youths who receive medication to treat opioid use is decreasing, with significant inequalities among population types.
For Contemporary Pediatrics, Dr Bobby Lazzara discusses a controversial UK-based study published in JAMA Pediatrics that examined how well pharmacologic interventions for ADHD help education and health outcomes for impacted kids.
ADVERTISEMENT
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%%
%%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%